Tenaya Therapeutics (TNYA)
NASDAQ:TNYA
US Market

Tenaya Therapeutics (TNYA) Financial Statements

396 Followers

Tenaya Therapeutics Financial Overview

Tenaya Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.683; its P/E ratio is -2.08; Tenaya Therapeutics is scheduled to report earnings on August 7, 2024, and the estimated EPS forecast is $-0.39. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -32.23M$ -29.93M$ -29.14M$ -33.27M$ -33.71M
EBITDA$ -29.34M$ -25.26M-$ -30.79M$ -35.81M
Net Income Common Stockholders$ -32.20M$ -29.95M$ -29.14M$ -33.27M$ -31.74M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 122.25M$ 104.64M$ 121.75M$ 132.50M$ 147.81M
Total Assets$ 184.90M$ 170.51M$ 193.40M$ 220.75M$ 245.34M
Total Debt$ 11.37M$ 12.42M$ 12.04M$ 13.10M$ 14.12M
Net Debt$ -110.88M$ -92.22M$ -109.71M$ -119.40M$ -133.69M
Total Liabilities$ 26.72M$ 31.09M$ 28.51M$ 30.81M$ 29.93M
Stockholders Equity$ 158.18M$ 139.42M$ 164.88M$ 189.94M$ 215.41M
Cash Flow-
Free Cash Flow$ -29.22M$ -22.32M-$ -26.41M$ -30.52M
Operating Cash Flow$ -28.66M$ -21.92M$ -23.64M$ -26.20M$ -29.89M
Investing Cash Flow$ -4.49M$ -14.92M$ 30.49M$ 25.09M$ 8.06M
Financing Cash Flow$ 46.77M$ 371.00K-$ 4.18M$ -501.00K
Currency in USD

Tenaya Therapeutics Earnings and Revenue History

Tenaya Therapeutics Debt to Assets

Tenaya Therapeutics Cash Flow

Tenaya Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis